Despite the development of newer and more effective antibiotic therapies, sepsis related mortality in neonates undergoing intensive care has remained constant for nearly two decades. The rate of infection among these neonates ranges from 25% to 50%, with bacterial infection remaining a major cause of death and long-term morbidity. The cost of caring for premature neonates, who are the most susceptible to infection, represents over 50% of the total dollars expended for neonatal intensive care unit (NICU) services. The unique susceptibility of the human neonate to serious and overwhelming bacterial infections relates in part to deficiencies of antibody, complement, and T lymphocytes. However, while deficiencies in these contribute to the neonate s susceptibility, neutrophil defects appear to be the major host defense abnormality. Functional defects in neonatal polymorphonuclear leukocyte adherence, aggregation, chemotaxis, phagocytosis, and intracellular killing have been described in both the term and preterm infant. Of these defects, neutrophil chemotaxis, as assessed by in vitro assays, is abnormal at birth. While term infants rapidly establish normal chemotactic function, the process of postnatal maturation begins two to three weeks after birth in the preterm infant and proceeds very slowly. Neutrophils follow a concentration gradient of chemotactic factors in their movement from the vascular compartment to the site of microbial invasion. Chemokines are chemotactic cytokines that largely control leukocyte migration. While considerable information has emerged in the past ten years related to the role of chemokines in the adult, very little information exists as to the physiologic significance of chemokines in the neonate. Candidate chemokine/chemokine receptors for influencing neutrophil chemotaxis include members of the CXC chemokines. We propose that understanding the gene regulation for the expression of specific chemokine receptors (CXCR) during development would enhance our understanding of chemotaxis in the neonate. We further propose that defining circulating concentrations of chemokines critical for neutrophil migration would be essential to understanding their role in both health and disease.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Research Grants (R03)
Project #
1R03HD042326-01
Application #
6486249
Study Section
Pediatrics Subcommittee (CHHD)
Program Officer
Lock, Allan
Project Start
2001-08-13
Project End
2003-07-31
Budget Start
2001-08-13
Budget End
2002-07-31
Support Year
1
Fiscal Year
2001
Total Cost
$72,500
Indirect Cost
Name
University of South Florida
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Fox, Samuel E; Lu, Wenge; Maheshwari, Akhil et al. (2005) The effects and comparative differences of neutrophil specific chemokines on neutrophil chemotaxis of the neonate. Cytokine 29:135-40
Lu, Wenge; Gersting, Jason A; Maheshwari, Akhil et al. (2005) Developmental expression of chemokine receptor genes in the human fetus. Early Hum Dev 81:489-96
Lu, Wenge; Maheshwari, Akhil; Misiuta, Iwona et al. (2005) Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells. Brain Res Dev Brain Res 155:127-34
Maheshwari, Akhil; Lu, Wenge; Guida, Wayne C et al. (2005) IL-8/CXC ligand 8 survives neonatal gastric digestion as a result of intrinsic aspartyl proteinase resistance. Pediatr Res 57:438-44
Kotto-Kome, Anne C; Calhoun, Darlene A; Montenegro, Raul et al. (2004) Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis. J Perinatol 24:11-5
Kotto-Kome, Anne C; Fox, Samuel E; Lu, Wenge et al. (2004) Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model. Pharmacol Res 50:55-8
Condino, Adria A; Barleycorn, Aaron A; Lu, Wenge et al. (2004) Abnormal intestinal histology in neonates with congenital anomalies of the gastrointestinal tract. Biol Neonate 85:145-50
Gersting, Jason A; Christensen, Robert D; Calhoun, Darlene A (2004) Effects of enterally administering granulocyte colony-stimulating factor to suckling mice. Pediatr Res 55:802-6
Kotto-Kome, Anne C; Garcia, Maria G; Calhoun, Darlene A et al. (2004) Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on ""early"" and ""late"" erythrocyte transfusions: a meta-analysis. J Perinatol 24:24-9
Maheshwari, Akhil; Lacson, Atilano; Lu, Wenge et al. (2004) Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 56:240-9

Showing the most recent 10 out of 22 publications